CTIC has a VERY promising cancer drug. They turned down a R/S this week and voted to double the outstanding shares - not a big deal IMHO for a stock that was $9 last year and $300 at one point. Speculation is they are going to get bought soon by Novartis, perhaps $5-10 per share. I bought in at .10 and what's happening today with CTIC is precisely why I don't want a day to go by without owning ACTC. It can run like this. The only issue now with CTIC is how much to hold and how much to take off the table. I only wish I owned as much CTIC as I did ACTC.